{
 "name": "訊聯智藥",
 "slug": "tw-7808",
 "aliases": [
  "訊聯細胞智藥股份有限公司",
  "BIONET TX Corp.",
  "7808"
 ],
 "ticker": "7808",
 "industry": "生技醫療業",
 "website": "https://www.bionettx.com/",
 "summary": "訊聯智藥（7808）是興櫃的生技醫療類股公司，2022 年成立，2024 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "訊聯細胞智藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "BIONET TX Corp.",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2024-12-12",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2022-06-15",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "蔡政憲",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "李黛苹",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 700000000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.bionettx.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：ExoHerb（清泌一號中草藥胞外體）",
   "value": "皮膚、毛髮與私密處保養｜已推出之保養品配方（非藥品）｜地區未揭露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.bionettx.com/exoherb/",
   "note": "公司產品新聞稿；不把化粧品原料、宣稱或研發合作視為醫療適應症或上市藥證。"
  },
  {
   "claim": "管線：ExoSecret（外泌體私密保養配方）",
   "value": "私密處外用保養｜已設計推出之保養配方（非藥品）｜地區未揭露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.bionettx.com/exoherb/",
   "note": "以清泌一號配方結合哺乳類外泌體；公司未在此來源公開藥證或銷售地區。"
  },
  {
   "claim": "管線：ExoRoots（外泌體煥髮精萃）",
   "value": "毛髮強健保養｜已推出之保養品（非藥品）｜地區未揭露",
   "unit": "",
   "as_of": "2025-04-30",
   "source": "https://www.bionettx.com/exoherb/",
   "note": "公司稿明列新品 ExoRoots，以清泌一號結合 AI 篩選 IGF-1 活性因子；不寫未經主管機關核准之治療效果。"
  },
  {
   "claim": "管線：ExoCream（人體幹細胞外泌體產品）",
   "value": "外用粧品保養｜AMWC Japan 展示產品與技術（非藥品）｜日本",
   "unit": "",
   "as_of": "2026-10-15",
   "source": "https://www.bionettx.com/media/2026-amwc-japan/",
   "note": "公司官方產品展會公告之文字內容；頁面同時明示保養品為外用化粧品、無醫療效能。不將日本展會展示等同醫材許可或臨床階段。"
  },
  {
   "claim": "管線：ExoSkin（人體幹細胞外泌體產品）",
   "value": "外用粧品保養｜AMWC Japan 展示產品與技術（非藥品）｜日本",
   "unit": "",
   "as_of": "2026-10-15",
   "source": "https://www.bionettx.com/media/2026-amwc-japan/",
   "note": "公司官方產品展會公告之文字內容；頁面同時明示保養品為外用化粧品、無醫療效能。不將日本展會展示等同醫材許可或臨床階段。"
  },
  {
   "claim": "管線：ExoHair（人體幹細胞外泌體產品）",
   "value": "外用粧品保養｜AMWC Japan 展示產品與技術（非藥品）｜日本",
   "unit": "",
   "as_of": "2026-10-15",
   "source": "https://www.bionettx.com/media/2026-amwc-japan/",
   "note": "公司官方產品展會公告之文字內容；頁面同時明示保養品為外用化粧品、無醫療效能。不將日本展會展示等同醫材許可或臨床階段。"
  },
  {
   "claim": "管線：UCMSC Exosomes（臍帶間質幹細胞外泌體藥物原料）",
   "value": "外泌體藥物原料與製程｜公司公告美國FDA第II類DMF登記申請獲核可｜美國",
   "unit": "",
   "as_of": "2025-07-29",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?seq_no=1&spoke_time=161422&spoke_date=20250729&TYPEK=rotc&firstin=true&step=2&co_id=7808&year=114&month=all&e_month=all",
   "note": "發言日期114/07/29 16:14:22；主旨：公告本公司開發之臍帶間質幹細胞外泌體藥物原料UCMSC Exosomes 已獲美FDA原料藥主檔案(DMF)登記申請核可；序號1。原文將DMF列為未來IND/NDA/BLA申請可引用的技術支援文件，未公開DMF號；不是藥品上市許可或臨床有效性結論。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-7808.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}